Breakthrough Personalized Cancer Care Technology
Foundation Medicine relies on a LIMS for integrating lab, clinical, and EMR data
Read More
Search Results for: lung cancer
QIAGEN Submits CDx to FDA to Guide Treatment Decisions for Investigational NSCLC Drug
QIAGEN continues to expand personalized health care portfolio and content menu for modules of the QIAsymphony automation platform.
Read More
Cell Signaling Technology Gets Patent for PCR Methods for Detection of Subset of Treatable NSCLC
The methods include the amplification of DNA or RNA fusion polynucleotides from patient blood, tissue, or cells and the determination of a therapeutic regimen based on the presence of the fusion in the sample.
Read More
Urine Test for a Rare and Elusive Disease
Proteins found in urine may enable diagnosis of Kawasaki disease.
Read More
News: Up Close with Insight
CLP recently spoke with David Hout, PhD, VP of R&D, Insight Genetics, about continuing work on the Insight ALK Screen, Insight ALK Resistance, and other biomarker-specific diagnostic tools to advance cancer care.
Read More